✦ LIBER ✦

P489 How often is dose escalation needed in patients with inflammatory bowel disease treated with anti-TNF?

✍ Scribed by Viazis, N.; Koukouratos, T.; Saprikis, E.; Al-Odat, M.; Anastasopoulos, E.; Zacharakis, G.; Karamanolis, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P381 Predictors and frequency of anti-TN

✍ Viazis, N.; Koukouratos, T.; Anastasiou, J.; Saprikis, E.; Kechagias, G.; Katopo 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 48 KB

DOP085 Success rate of dose de-escalatio

✍ Viazis, N.; Anastasiou, J.; Koukouratos, T.; Giakoumis, M.; Anastasopoulos, E.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 49 KB

P386 Refractory inflammatory bowel disea

✍ Gubonina, I.; Pershko, A.; Dragun, A. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 116 KB

P.08.17 MUCOSAL HEALING IN PATIENTS WITH

✍ Bravatà, I.; Cappello, M.; Calvaruso, V.; Attardo, S.; Peralta, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Onset of psoriasis in patients with infl

✍ Guerra, Iván; Gisbert, Javier P 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 910 KB

P448 Inflammatory and cancerous skin les

✍ Ocepek, A.; Pernat Drobez, C. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 155 KB